China Is Top International Priority For AdvaMed's New Chairman
This article was originally published in The Gray Sheet
Executive Summary
AdvaMed's new chairman, Jim Mazzo, cites regulatory roadblocks in China as the most important international marketing issue facing U.S. device manufacturers